Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Revance Therapeutics Inc. buy melinda

Revance Therapeutics Inc.
Start price
€18.22
21.05.17 / 50%
Target price
€20.75
26.05.17
Performance (%)
6.19%
End price
€19.35
26.05.17
Summary
This prediction ended on 26.05.17 with a price of €19.35. With a performance of 6.19%, the BUY prediction by melinda for Revance Therapeutics Inc. closed with a slight gain. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Revance Therapeutics Inc. - - - -
iShares Core DAX® 3.002% 4.755% 23.700% 68.627%
iShares Nasdaq 100 2.966% 0.363% 8.027% 116.238%
iShares Nikkei 225® 5.606% 4.528% 20.313% 56.217%
iShares S&P 500 2.312% 1.811% 5.451% 70.924%

According to melinda what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Revance Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 6.19%
Target price 20.746
Change
Ends at 26.05.17

Gesundheit | Biotechnologie | Vereinigte Staaten

$

melinda 
0
Report Share
21.05.17
Prediction Buy
Perf. (%) 6.19%
Target price 20.746
Change
Ends at 26.05.17

(Vom Mitglied beendet)

melinda 
0
Report Share
26.05.17

Stopped prediction by melinda for Revance Therapeutics Inc.

buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
melinda 
01.11.21 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.50
28.11.20
€23.00
28.11.21
-36.41%
01.11.21

Could be worthwhile Investment >10% per year
melinda 
28.11.20 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€24.40
09.02.20
-
04.11.21
-20.08%
28.11.20

Could be worthwhile Investment >10% per year
melinda 
09.02.20 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.44
09.02.20
-
09.02.20
-
09.02.20

Could be worthwhile Investment >10% per year
melinda 
09.02.20 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.44
09.02.20
-
09.02.20
-
09.02.20

Could be worthwhile Investment >10% per year
melinda 
09.02.20 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€23.40
07.02.20
-
09.02.20
4.27%
09.02.20

Could be worthwhile Investment >10% per year
melinda 
07.02.20 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€26.38
10.05.18
€30.04
08.11.18
-17.74%
08.11.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€26.38
10.05.18
€30.04
10.05.18
0.00%
10.05.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.20
21.05.17
€23.00
26.05.17
6.19%
26.05.17

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.47
10.05.16
€17.14
24.05.16
11.20%
24.05.16

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%